Clinical Trials Browser

Unknown × Thoracic × Clear all

NCT05599789 2025-02-18

KeyPemls-004

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06733311 2024-12-13

UPD-LC

Lung Neoplasms

NCT06703866 2024-11-25

VBM

Lung Neoplasms

NCT06215885 2024-09-24

Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules

Adenocarcinoma of Lung

NCT06586697 2024-09-19

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT05996263 2024-08-09

PEMBROMIC

Lung Neoplasms

NCT06531850 2024-08-01

Prospective Study of Serum Marker LncRNA RP5-977B1 in Pulmonary Nodules

Lung Neoplasms

NCT04922658 2024-07-31

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Phase 2 Unknown

Advanced Non-Small Cell Lung Cancer

NCT06128694 2024-07-30

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Phase 3 Unknown

GynecologicThoracic

Uterine Cervical Neoplasms, Kwashiorkor, Lung Neoplasms, Neoplasms, Malnutrition

NCT06256055 2024-07-24

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Phase 1 Unknown

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Bile Duct Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05183243 2024-07-16

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Phase 1 Unknown

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT03721133 2024-05-22

Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients

Lung Cancer Recurrent

NCT03724500 2024-05-22

Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT06406673 2024-05-09

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Phase 2 Unknown

Extensive Small Cell Lung Cancer

NCT05735028 2024-04-17

The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

Phase 1 Unknown

Lung Neoplasms

NCT06363123 2024-04-15

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06150131 2024-04-12

Exercise Intervention After Lung Cancer Surgery

Phase NA Unknown

Rehabilitation After Lung Cancer Surgery

NCT06356701 2024-04-10

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Phase 1 Unknown

Lung Neoplasms

NCT06349252 2024-04-05

Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06344962 2024-04-03

Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT06341387 2024-04-02

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT06341530 2024-04-02

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06341660 2024-04-02

To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06342323 2024-04-02

ONFM-SBRT

GastrointestinalGenitourinaryThoracic

Carcinoma, Renal Cell, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Phase 1 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06339242 2024-04-01

A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis

Phase 2 Unknown

NSCLC

NCT03893539 2024-03-29

Clinical Utility for Ion Endoluminal System

Phase NA Unknown

Lung Diseases, Lung Neoplasms

NCT04209868 2024-03-29

ParaSOL

Phase 2/3 Unknown

Thoracic Neoplasms

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06286592 2024-03-29

LUNGevity: Lung Cancer Stigma Community Based Participatory Research

Phase NA Unknown

Lung Neoplasms, Neoplasms, Smoking Cessation

NCT06334757 2024-03-28

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

Phase 2 Unknown

Non-Squamous Non-Small Cell Lung Cancer

NCT06335290 2024-03-28

Radiotherapy Treatments for the Treatment of Thoracic District Tumors

13,200 enrolled

Thoracic Neoplasms

NCT05775068 2024-03-27

ARGOS

Lung Neoplasms

NCT06323265 2024-03-27

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer

NCT06332287 2024-03-27

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis

Phase 2 Unknown

NSCLC

NCT06106152 2024-03-26

WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody

Phase EARLY_PHASE1 Unknown

Advanced Lung Cancer

NCT06331650 2024-03-26

A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02619448 2024-03-25

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06195189 2024-03-25

WU-KONG36

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06328049 2024-03-25

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

Phase 2 Unknown

NSCLC

NCT06326086 2024-03-22

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

Carcinoma, Non-Small-Cell Lung, Sarcopenia

NCT03322072 2024-03-20

GPS

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06321640 2024-03-20

POSITive

BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT05649046 2024-03-18

PREVALUNG*

Phase NA Unknown

Lung Neoplasms, Bronchitis, Chronic, Plaque, Atherosclerotic

NCT04903873 2024-03-15

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Phase 1/2 Unknown

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT05801133 2024-03-15

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

Phase 2 Unknown

Lung Neoplasms

NCT06310915 2024-03-15

Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

Non-small Cell Lung Cancer Stage IIIB/IV

NCT06285058 2024-03-13

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

Carcinoma, Non-Small-Cell Lung